Cannabis in the United Kingdom

Cannabis in the United Kingdom

2023 presented quite a mixed picture for the cannabis industry in the UK. While growth continued, there was also a modification regarding the future expectations of development within the local market. In CBD & other non-intoxicating cannabinoids, 2023 retail sales plateaued amidst the enduring situation with the Novel Foods legislation. CBD & other non-intoxicating cannabinoids was also affected by the high cost of living which punctuated much of the year, with consumers facing reduced disposab...

Euromonitor International's Cannabis in United Kingdom market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2028 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.